A Delaware federal jury found that Arm breached its architectural license agreement with Qualcomm and intentionally interfered with Qualcomm’s business relationship with Meta Platforms. It awarded Qualcomm just $2 in nominal damages, leaving both companies able to point to parts of the October 13, 2026, verdict as a win.
3
4
11
What the jury decided
The jury found for Qualcomm on two claims: breach of the licensing agreement and intentional interference with its relationship with Meta. Arm, meanwhile, said jurors found in its favor on four other claims and awarded Qualcomm $1 on each of the two claims it won.
3
11
The award was nominal, not a payment reflecting the larger commercial losses Qualcomm alleged during the case. Qualcomm claimed that an alleged disclosure by Arm contributed to a $170 million reduction in the value of a potential Meta deal; Arm disputed that connection. The available reporting does not establish that the jury accepted Qualcomm’s estimate or explain its precise reasoning for awarding only $2.
11
38
The contract and Meta allegations
Qualcomm alleged that Arm withheld software patches and chip-testing tools that Qualcomm needed under its agreement. Trial coverage also described the tools as relevant to testing Qualcomm’s chip designs. The jury’s breach finding supports Qualcomm on a contract claim, but the verdict does not mean every allegation made at trial was upheld.
2
8
17
The Meta dispute centered on Qualcomm’s allegation that Arm disclosed a 2024 warning about terminating a key license while Qualcomm was pursuing a business relationship with Meta. Qualcomm said the disclosure harmed the potential deal; Arm disputed the claimed connection to the deal’s economics. These were contested claims presented in the litigation, not all findings established by the verdict.
26
38
Why both companies claimed vindication
Qualcomm emphasized that the jury found a breach and intentional interference. Arm emphasized that it prevailed on four other claims, the award totaled only $2, and the verdict supported its good-faith position. Arm also accused Qualcomm of pursuing the case to deprive it of billions of dollars in licensing payments. That characterization is Arm’s position, not a separate jury finding.
7
11
The result is best understood as mixed: Qualcomm secured two significant legal findings, while the small nominal award and Arm’s wins on other claims limited the practical result described in the available coverage. The sources do not establish that the $2 award alone resolves the companies’ wider royalty dispute.
2
11
What happened to the shares
Market reports captured different points in trading. Reuters reported that Arm shares were down about 1% after the verdict while Qualcomm shares were up about 1%; a later Investing.com report said Arm had erased earlier gains and fallen more than 3%. These figures reflect different reporting snapshots, rather than a single definitive closing reaction.
18
19
22
A dispute between former partners, with more questions remaining
The verdict followed a five-day trial and was the companies’ second trial in two years. Reuters described the broader relationship as deteriorating after SoftBank took control of Arm in 2016 and Arm shifted from licensing chip technology toward selling its own chips.
3
4
The disagreement sits alongside a separate, earlier dispute over Qualcomm’s acquisition of Nuvia. The supplied reporting says Arm sued Qualcomm in 2022 following the acquisition, but does not provide enough reliable detail to verify the full later court history.
37
Nor did the jury’s $2 award settle every issue. Reporting said questions about royalties and negotiations remained for U.S. District Judge Maryellen Noreika. The available sources do not establish the final outcome of those remaining matters.
2